Structural Basis of ALDH1A2 Inhibition by Irreversible and Reversible Small Molecule Inhibitors
Enzymes of the ALDH1A subfamily of aldehyde dehydrogenases are crucial in regulating retinoic acid (RA) signaling and have received attention as potential drug targets. ALDH1A2 is the primary RA-synthesizing enzyme in mammalian spermatogenesis and is therefore considered a viable drug target for male contraceptive development. However, only a small number of ALDH1A2 inhibitors have been reported, and information on the structure of ALDH1A2 was limited to the NAD-liganded enzyme void of substrate or inhibitors. Herein, we describe the mechanism of action of structurally unrelated reversible and irreversible inhibitors of human ALDH1A2 using direct binding studies and X-ray crystallography. All inhibitors bind to the active sites of tetrameric ALDH1A2. Compound WIN18,446 covalently reacts with the side chain of the catalytic residue Cys320, resulting in a chiral adduct in (R) configuration. The covalent adduct directly affects the neighboring NAD molecule, which assumes a contracted conformation suboptimal for the dehydrogenase reaction. The reversible inhibitors interact predominantly through direct hydrogen bonding interactions with residues in the vicinity of Cys320 without affecting NAD. Upon interaction with inhibitors, a large flexible loop assumes regular structure, thereby shielding the active site from solvent. We conclude the precise knowledge of the binding modes provides a new framework for the rational design of novel inhibitors of ALDH1A2 with improved potency and selectivity profiles.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute for Child Health & Human Development (NICHD)
- Grant/Contract Number:
- P30-CA076292; HHSN275201300017C; U54HD04245
- OSTI ID:
- 1435823
- Journal Information:
- ACS Chemical Biology, Vol. 13, Issue 3; ISSN 1554-8929
- Publisher:
- American Chemical Society (ACS)Copyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Web of Science
Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature: Influence of RA on Coronary Development
|
journal | August 2018 |
Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it
|
journal | April 2019 |
| Recent insights on the role and regulation of retinoic acid signaling during epicardial development | journal | May 2019 |
Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods
|
journal | January 2019 |
Development of Novel Male Contraceptives
|
journal | November 2019 |
Similar Records
Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS
Consequences of Lineage-Specific Gene Loss on Functional Evolution of Surviving Paralogs: ALDH1A and Retinoic Acid Signaling in Vertebrate Genomes